Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Bullboard Posts
Comment by bilosellhion Jul 13, 2004 6:45pm
357 Views
Post# 7705096

RE: I continue to be amazed

RE: I continue to be amazeddangerous you may be right that this is all due to manipulation, but imo, the ultimate responsibility for creating the environment for such manipulation to happen is born by none other than BT & onc management (and some posters here who hype this stock, especially when it is going up. BT's self-imposed news blackouts on onc's clinical trials until final results are in hand, being non-committal to timelines for the commencement of US glio or NIH trials, etc., numerous examples of poor investor relations & news releases...eg. "there is nothing material happening at the company", making light of forward looking statement protection to an institutional investor audience, saying there were no safety issues with glio when the phase I safety trial was halted for 6 months, etc. then you have the pumpers & hypers, who, if you read their posting history, never ever suggest this stock could go down no matter what - it seems beyond their capacity to consider market forces on the downside, only on the upside. this may be an expensive lesson for some, and for that matter, my paper profits have taken a fair hit, though i've been buying the last two days, more as the price goes lower and plan to buy more tomorrow. that is as much if not more due to my view that market forces that brought this stock down will help it recover, than any great confidence in BT & onc. if you didn't expect this kind of volatility with a stock like onc & their management, then welcome to the world of small cap biotechs.
Bullboard Posts